Lou is the Chief Executive Officer of TMRW Life Sciences.
Lou brings over thirty years of global healthcare leadership experience and was most recently CEO of Genea Biomedx , a fertility technology, and medical device company focused on the automation and standardization of embryologist and lab workflow. While at Genea Biomedx , he led the transition from a commercial partnership with Merck Serono / KGaA to the creation of a standalone commercial organization spanning Europe, Asia, and the US, ultimately leading a successful sale of the business to private equity. Lou has also served in various senior leadership positions across healthcare, including OvaScience , Evofem Biosciences, and Auxogyn / Progyny. Prior to these, he was the Executive Vice President of Europe for Conceptus, Inc., and was a key leader in the team that completed the $1.1 billion sale of the company to Bayer AG in 2013.
